SMART Health Cards: Terminology
0.1.0 - ci-build
SMART Health Cards: Terminology - Local Development build (v0.1.0). See the Directory of published versions
| Official URL: https://github.com/dvci/shc-terminology/ConceptMap/covid-mapping-cvx-air | Version: 2022.1 | |||
| Draft as of 2021-09-22 | Realm: Australia | Computable Name: ImmunizationCovidCVXAirConceptMap | ||
Copyright/Legal: Creative Commons 0 |
||||
A Mapping between CVX and AIR Codes for Covid vaccinations. This mapping is bi-directional - one group for each direction
Mapping from (not specified) to (not specified)
DRAFT. Published on 2021-09-22 by VCI (VCI: https://vci.org). Creative Commons 0
A Mapping between CVX and AIR Codes for Covid vaccinations. This mapping is bi-directional - one group for each direction
Group 1Mapping from https://www.humanservices.gov.au/organisations/health-professionals/enablers/air-vaccine-code-formats|20210222 to PH_VaccinesAdministeredCVX_CDC_NIP
| Source Code | Relationship | Target Code |
| COVAST (COVID-19 Vaccine AstraZeneca) | is equivalent to | 210 (COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL) |
| COMIRN (Pfizer Comirnaty) | is equivalent to | 208 (COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose) |
| MODERN (Moderna Spikevax) | is equivalent to | 207 (COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose) |
Group 2Mapping from PH_VaccinesAdministeredCVX_CDC_NIP to https://www.humanservices.gov.au/organisations/health-professionals/enablers/air-vaccine-code-formats|20210222
| Source Code | Relationship | Target Code |
| 210 (COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL) | is equivalent to | COVAST (COVID-19 Vaccine AstraZeneca) |
| 208 (COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose) | is equivalent to | COMIRN (Pfizer Comirnaty) |
| 207 (COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose) | is equivalent to | MODERN (Moderna Spikevax) |
| 211 (COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL) | (not mapped) | |
| 212 (COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL) | (not mapped) | |
| 213 (SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED) | (not mapped) | |
| 217 (COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose) | (not mapped) | |
| 218 (COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose) | (not mapped) | |
| 219 (COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose) | (not mapped) | |
| 500 (COVID-19 Non-US Vaccine, Product Unknown) | (not mapped) | |
| 501 (COVID-19 IV Non-US Vaccine (QAZCOVID-IN)) | (not mapped) | |
| 502 (COVID-19 IV Non-US Vaccine (COVAXIN)) | (not mapped) | |
| 503 (COVID-19 LAV Non-US Vaccine (COVIVAC)) | (not mapped) | |
| 504 (COVID-19 VVnr Non-US Vaccine (Sputnik Light)) | (not mapped) | |
| 505 (COVID-19 VVnr Non-US Vaccine (Sputnik V)) | (not mapped) | |
| 506 (COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology)) | (not mapped) | |
| 507 (COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)) | (not mapped) | |
| 508 (COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)) | (not mapped) | |
| 509 (COVID-19 PS Non-US Vaccine (EpiVacCorona)) | (not mapped) | |
| 510 (COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)) | (not mapped) | |
| 511 (COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)) | (not mapped) | |